Skip to search formSkip to main contentSkip to account menu

ANRIL long non-coding RNA, human

Known as: CDKN2B-AS long non-coding RNA, human, CDKN2B antisense RNA, human, antisense noncoding RNA in the INK4 locus, human 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Although the roles of long non‐coding RNA (lncRNA) ANRIL (Antisense non‐coding RNA in the INK4A locus) have been established in… 
2019
2019
OBJECTIVE To investigate the role of the long non-coding ribonucleic acid (lncRNA) antisense non-coding RNA in the INK4 locus… 
Highly Cited
2018
Highly Cited
2018
This study was designed to investigate whether ANRIL affected the aetiology of coronary artery disease (CAD) by acting on… 
Highly Cited
2017
Highly Cited
2017
Background: Triple-negative breast cancer (TNBC) is an aggressive cancer with unfavorable outcome and it is useful to explore… 
Highly Cited
2017
Highly Cited
2017
Platinum-based chemotherapy is the standard first-line treatment for most lung cancer patients. However, the toxicity induced by… 
Highly Cited
2016
Highly Cited
2016
ABSTRACT Antisense Noncoding RNA in the INK4 Locus (ANRIL) is the prime candidate gene at Chr9p21, the well-defined genetic risk… 
2016
2016
Some studies investigated the association of antisense non-coding RNA in the INK4 locus (ANRIL) rs2383207 polymorphism with… 
2016
2016
The exonic ANRIL (P15AS) is a 3.8-kb lncRNA transcribed from the antisense strand of the P14 promoter and flanking regions…